NCT05614622View on ClinicalTrials.gov

Mydriatic Drops After Combined Surgery

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 10, 2020

Primary Completion Date

January 3, 2022

Study Completion Date

January 3, 2022

Conditions
Posterior Synechiae of Iris
Interventions
DRUG

Cyclopentolate Hydrochloride 1.0% eye drops

A short-acting mydriatic agent

Trial Locations (1)

4941492

Rabin Medical Center, Petah Tikva

All Listed Sponsors
lead

Rabin Medical Center

OTHER

NCT05614622 - Mydriatic Drops After Combined Surgery | Biotech Hunter | Biotech Hunter